BPC-157

What Is BPC-157?

BPC-157 (“Body Protection Compound 157”) is a synthetic pentadecapeptide — a 15-amino-acid sequence originally isolated as a fragment of a protein found in gastric juice. It is supplied by CertaPeptides as a research-grade lyophilized powder for in vitro and preclinical research use.

CAS: 137525-51-0. Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val.

What Published Research Has Reported

The statements below are direct attributions to peer-reviewed preclinical studies. They describe observations in animal models or in vitro systems only and should not be interpreted as human clinical claims.

• Sikiric et al. (2014) reviewed the role of the nitric oxide system in rodent BPC-157 studies and reported interactions between the pentadecapeptide and NO-pathway modulators in gastrointestinal and vascular experimental models. Source: Current Pharmaceutical Design, 20(7), 1126–1135. PMID 23755725.
• Chang et al. (2014) reported that, in cultured rat Achilles tendon fibroblasts, BPC-157 exposure was associated with increased growth hormone receptor expression compared to control. Source: Molecules, 19(11), 19066–19077. PMID 25415472.
• Krivic et al. (2008) observed, in a rat Achilles tendon-to-bone transection model, differences in early functional recovery measurements between BPC-157-treated animals and controls. Source: Inflammation Research, 57(5), 205–210. PMID 18594781.
• Staresinic et al. (2006) reported outcome measurements after application of BPC-157 in a rat transected-quadriceps model. Source: Journal of Orthopaedic Research, 24(5), 1109–1117. PMID 16609979.

Research Areas Where BPC-157 Is Studied

• Preclinical models of musculoskeletal tissue response (rodent tendon, ligament, muscle)
• In vitro fibroblast and endothelial cell culture assays
• Experimental gastrointestinal mucosa models in rats and mice
• Nitric-oxide pathway signalling studies in animal tissue

Specifications

Numer CAS	137525-51-0
Sekwencja	Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Wzór cząsteczkowy	C62H98N16O22
Masa cząsteczkowa	1419.53 g/mol
Czystość	≥98% (class-level specification)
Physical Form	Lyophilized (freeze-dried) powder
Salt form	Acetate (standard BPC-157, not arginate/PDA)
Available Sizes	2mg, 5mg, 10mg, 20mg

Przechowywanie

Lyophilized: store unopened vials at −20°C. 2–8°C for short-term use.

Reconstituted: 2–8°C, use within 4 weeks. Do not freeze after reconstitution.

Quality Assurance

• Class-level specification ≥98%
• Selected lots are independently tested by Janoshik Analytical
• Independent reports searchable by batch or report code at certapeptides.com/verify
• Sold and shipped from the EU by CERTALAB S.R.L.

Important Notice — For Research Purposes Only

BPC-157 is supplied by CertaPeptides strictly as a laboratory research compound. The findings cited above are taken from preclinical, animal-model, and in vitro studies and are reported here for research context only. They are not medical claims. BPC-157 is supplied for laboratory research and is not for use in humans or animals. For laboratory research purposes only. Not for human consumption.